Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-01-11
1997-12-09
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514456, A61K 3140, A61K 3135
Patent
active
056961499
ABSTRACT:
The present invention provides novel uses of compounds of general formula I ##STR1## wherein R.sup.1, R.sup.4 and R.sup.5 are individually hydrogen, hydroxy, halogen, trifiuoromethyl, lower alkyl, lower alkoxy or (tertiary amino)(lower alkoxy); and R.sup.2 and R.sup.3 are individually hydrogen or lower alkyl, or as a pharmaceutically acceptable salt thereof in combination with a pharmaceutically acceptable carrier for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of cerebral degenerative disorders.
REFERENCES:
patent: 3822287 (1974-07-01), Bolger
patent: 4447622 (1984-05-01), Salman et al.
patent: 5280040 (1994-01-01), Labroo et al.
patent: 5451603 (1995-09-01), Piggott
patent: 5480903 (1996-01-01), Piggott
Ray et al. "An X-ray Crytallographic Study of the Nonsteroidal Contraceptive Agent Centchroman", J. Med. Chem. Soc., vol. 37, pp. 696-700 (1993) 1994.
Guldhammer Birgitte Hjort
Korsgaard Niels
Shalmi Michael
Agris Cheryl H.
Henley III Raymond
Novo Nordisk A S
Zelson Steve T.
LandOfFree
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceut does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of 3,4-diphenyl chromans for the manufacture of a pharmaceut, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of 3,4-diphenyl chromans for the manufacture of a pharmaceut will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1608115